Instruction for use: Ornicetil

Active substance Ornithine

ATX code A05BA Preparations for the treatment of liver diseases

Pharmacological group

Detoxifying agents, including antidotes

Hepatoprotectors

Nosological classification (ICD-10)

G93.4 Unspecified encephalopathy

Bilirubin encephalopathy, Lacunar status, Tremor in portal-systemic encephalopathy, Latent hepatic encephalopathy, Atherosclerotic encephalopathy, Hypertonic encephalopathy, Hypoxic encephalopathy, Dysmetabolic encephalopathy, Encephalopathy,Defeat of the brain, Porto-caval encephalopathy, Vascular encephalopathy, Traumatic encephalopathy, Encephalopathy, Encephalopathy of secondary origin, Encephalopathy dyscirculatory, Encephalopathy portocaval, Epileptic encephalopathy, Syndrome of hemorrhagic shock and encephalopathy, Subacute spongiform encephalopathy

K72.9 Hepatic insufficiency, unspecified

Latent hepatic encephalopathy, Acute liver failure, Liver failure, Hepatic precoma, Acute hepatic-renal failure

K73 Chronic hepatitis, not elsewhere classified

Inflammatory liver disease, Hepatitis autoimmune, Hepatitis chronic, Infection of the liver, Chronic hepatitis with signs of cholestasis, Chronic reactive hepatitis, Chronic persistent hepatitis, Chronic infectious hepatitis, Chronic active hepatitis, Chronic inflammatory liver disease, Autoimmune Hepatitis, Chronic hepatitis is aggressive

K74 Fibrosis and cirrhosis of the liver

Otecno-ascitic syndrome with cirrhosis of the liver, Inflammatory liver disease, Precircrotic condition, Cystic fibrosis of the liver, Cirrhotic and precircotic state, Cirrhosis with portal hypertension, Cirrhosis of the liver with portal hypertension and edematous-ascitic syndrome, Cirrhosis of the liver with portal hypertension, Cirrhosis of the liver with ascites and edema, Cirrhosis of the liver with ascites, Cirrhotic ascites

R10.4 Other and unspecified abdominal pain

Abdominal pain, Gastrointestinal spasm, intestinal colic, Colic in infants, The feeling of fullness, Resi abdominal, Spasm of smooth muscle in diseases of the digestive tract, The spasm of the biliary tract, Biliary tract spasm, enterospasm, Spasm of the digestive tract, Spasms of the digestive tract smooth muscle, stomach Cramps, gastrointestinal spasms, Spastic condition of the gastrointestinal tract, intestinal tenesmus, Feeling of fullness, Baby colic

T51 Toxic effect of alcohol

Intoxication alcoholic, Alcohol intoxication, Intoxication with alcohol, Acute alcohol intoxication, Chronic alcohol intoxication

Composition and release form

1 bottle of powder for the preparation of injection solution contains ornithine alpha ketoglutarate 5 g; in a carton one bottle.

pharmachologic effect

Pharmacological action - hypoazotemic, hepatoprotective, detoxification.

Indications

Hyperammonemia, hepatoencephalitis, chronic alcohol intoxication, hepatitis, cirrhosis of the liver, severe liver failure, hepatic colic, coma, acute hepatitis, portocaval encephalopathy.

Contraindications

Severe renal failure (creatinine level more than 3 mg / 100 ml).

Sideeffects

In some cases, nausea, vomiting.

Interaction

Incompatible with penicillin, vitamin K, rifampicin, meprobamate, diazepam, phenobarbital, ethionamide.

Dosage and administration

In / in (struino, drip), in / m. For intravenous infusion or perfusion, 5 g of the powder dissolved in 10 ml of distilled water is introduced into the infusion solution (saline, blood substitutes, glucose, etc.) and infused (40 drops / min or slower - from 2 to 12 hours), 5 –10 vials per day.

Storage conditions

In a place protected from light and moisture, at a temperature of 10–25 ° C.

Keep out of the reach of children.

Shelf life

3 years.

Do not use after the expiration date printed on the package.